| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
U.S. stock futures were higher this morning, with the Dow futures gaining more than 150 points on Monday.
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) fell sharply in today's pre-market trading after the company suspended ELEVIDYS shipments and paused ENVISION trial after second fatal liver failure in non-ambulatory Duchenne patients.
Sarepta Therapeutics shares tumbled 31.4% to $24.86 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
Now Read This:
Photo via Shutterstock